IP Library › Granted Patent US 11,371,060
Granted Patent B2
US 11,371,060 · App. 16/484,252 · Granted Jun 28, 2022

SYNP88, a promoter for the specific expression of genes in retinal ganglion cells

Inventors: Botond Roska (Oberwil, CH); Josephine Juettner (Basel, CH)
Assignee: FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH
C12N15/86A61K48/0058C12N2750/14143C12N2830/008C12N2830/85
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,371,060
App. No.
16/484,252
Granted
Jun 28, 2022
Kind
B2
Abstract

The present invention provides an isolated nucleic acid molecule comprising, or consisting of, the nucleic acid sequence of SEQ ID NO:1 or a nucleic acid sequence of at least 1800 bp having at least 80% identity to said sequence of SEQ ID NO:1, wherein said isolated nucleic acid molecule specifically leads to the expression in retinal ganglion cells of a gene when operatively linked to a nucleic acid sequence coding for said gene.

Claims (16)

1. An expression cassette comprising an isolated nucleic acid molecule, the isolated nucleic acid molecule comprising the nucleic acid sequence of SEQ ID NO: 1, wherein said isolated nucleic acid molecule is operatively linked to at least a nucleic acid sequence encoding for a gene, said nucleic acid sequence encoding for a gene being heterologous to the isolated nucleic acid molecule, and wherein said isolated nucleic acid molecule is effective to drive expression of the gene in a retinal ganglion cell.

2. The expression cassette of claim 1 , wherein the isolated nucleic acid molecule further comprises a minimal promoter.

3. A vector comprising the expression cassette of claim 1 .

4. The vector of claim 3 , wherein said vector is a viral vector.

5. A method of expressing a gene in a retinal ganglion cell, the method comprising transfecting an isolated cell, a cell line, or a cell population with said expression cassette according to claim 1 , wherein said isolated cell is a retinal ganglion cell, or said cell line or said cell population comprises a retinal ganglion cell.

6. An isolated cell comprising the expression cassette of claim 1 .

7. The isolated cell of claim 6 , wherein the expression cassette is stably integrated into the genome of said cell.

8. The expression cassette of claim 1 , wherein the product of the gene is a light-sensitive molecule.

9. A kit for expressing a gene in retinal ganglion cells, the kit comprising said expression cassette according to claim 1 .

10. The expression cassette of claim 2 , wherein said minimal promoter comprises the nucleic acid sequence of SEQ ID NO: 2.

11. The expression cassette of claim 1 , wherein the product of the gene is selected from the group consisting of a light-sensitive molecule, MT-ND4, MT-ND1, MT-ND6, MT-CYB, MT-CO3, MT-ND5, MT-ND2, 5 MT-COI, MT-ATP6, MT-ND4L, OPA1, OPA3, OPA7, ACO2, GDNF, CNTF, FGF2, BDNF, EPO, BCL2, BCL2L 1, endostatin, angiostatin, and sFlt, IL 10, IL 1 R1, TGFBI, IL4, and rod-derived cone viability factor (RdCVF).

12. The vector of claim 3 , wherein the vector is an adeno-associated virus (AAV) vector.

13. The method of claim 5 , wherein the retinal ganglion cell is a rodent retinal ganglion cell.

14. The method of claim 5 , wherein the retinal ganglion cell is a non-human primate retinal ganglion cell.

15. The method of claim 5 , wherein the retinal ganglion cell is a human retinal ganglion cell.

16. The expression cassette of claim 8 , wherein the light-sensitive molecule is selected from the group consisting of a channelrhodopsin and a halorhodopsin.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 7, 2019
From: JUETTNER, JOSEPHINE; ROSKA, BOTOND
To: FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH
Reel/Frame 050940/0673 →
Priority Claims (1)
EP 17155193 · Feb 8, 2017 · regional
Continuity (1)
Related Publication 20200277626A1 · Sep 3, 2020